Table 3.
Comparison of postoperative complications between the two groups.
| Control group (n = 199) | Study group (n = 134) | p-value | |
|---|---|---|---|
| DVT | 8 (4.02%) | 10 (7.46%) | 0.199 |
| PE | 5 (2.51%) | 8 (5.97%) | 0.140 |
| Delirium | 62 (31.16%) | 48 (35.82%) | 0.376 |
| Readmission | 5 (2.51%) | 1 (0.75%) | 0.188 |
| In-hospital mortality | 4 (2.01%) | 4 (2.99%) | 0.570 |
| 1-month mortality | 5 (2.51%) | 4 (2.99%) | 0.795 |
| 1-year mortality | 9 (4.52%) | 8 (5.97%) | 0.558 |
| Medical complications | 94 (47.24%) | 40 (29.85%) | 0.001 |
| Cardiovascular | 6 | 2 | |
| Pulmonary | 38 | 24 | |
| Cerebrovascular | 2 | 4 | |
| Nephrologic | 18 | 4 | |
| Urologic | 20 | 9 | |
| Gastrointestinal | 15 | 2 | |
| Surgical complications | 5 (2.51%) | 1 (0.75%) | 0.188 |
| Dislocation | 1 | 1 | |
| PJI | 1 | 0 | |
| Wound infection | 3 | 0 |
DVT deep vein thrombosis, PE pulmonary embolism, PJI periprosthetic joint infection. Significant values are in bold.